DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Odronextamab Shows High Response Rates in R/R FL Feb 07, 2024
Lymphoma,MCL (Mantle Cell Lymphoma) Innovative MCL Prognostic Models: Integrative Analysis Feb 07, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Cuproptosis & Immunogenic Cell Death Model for Diffuse DLBCL Feb 07, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia CLL Risk: Second Malignancies in Treated vs Untreated Patients Feb 06, 2024
Lung Cancer,SCLC (Small Cell Lung Cancer) CT Radiomics and Clinical Factors in Limited SCLC Feb 06, 2024
Gastric Cancer,Gastrointestinal Cancer Regional Analysis of FLOT ± Durvalumab in Resectable GC/GEJC Feb 06, 2024
